baber/WOPTO huggingface dataset:
Patent NZ-334652-A (NZ)
Title: Thermostable DNA polymerase from Carboxydothermus hydrogenoformans
Inventor: ANKENBAUER WALTRAUD
IPC: C12N15/52
Filed: 1997-10-01
Abstract: A purified thermostable DNA polymerase exhibiting 3'-5' exonuclease activity obtainable from Carboxydothermus hydrogenoformans that catalyses the template directed polymerisation of DNA and has reverse transcriptase activity in the presence of magnesium ions and in the absence of manganese ions wherein the magnesium ions dependent reverse transcriptase activity of the polymerase is at least 100% of the manganese dependent reverse transcriptase activity of the polymerase. The polymerase has a MW 100-105kDa obtainable from E.coli BL21 (DE3) pUBS520 pAR4, DSM No. 11179. Further claimed is a recombinant DNA encoding the above polymerase, vector, microbial host, and process for preparation of DNA polymerase.
Patent NZ-335539-A (NZ)
Title: Radiopharmaceuticals for imaging infection and useful for inflammation
Inventor: BARRETT JOHN ANDREW
IPC: C07D405/14
Filed: 1997-10-06
Abstract: A compound comprising: a) a receptor binding moiety; b) a chelator; and c) an optional linking group between the receptor binding moiety and chelator; or pharmaceutically acceptable salts thereof; wherein: -the receptor binding moiety is a Leukotriene B4 (LTB4) receptor binding moiety, and -the compound has a binding affinity for LBT4 receptor of less than 1000nM -the LBT4 receptor binding moiety is not an antibody or a peptide. Also disclosed are kits comprising the compound described above, and optionally also containing other agents such as reducing agents or ancillary ligands (e.g. tricine and TPPTS). Also disclosed is a radio-labeled LBT4 binding agent, which comprises: a) the compound described above; b) a radioisotope selected from 99mTc, 111In, 95Tc, 62Cu, 67Ga, 68Ga, 123I, 125I, 18F, 11C, 13N, 15O, and 75Br. Also disclosed is a method of detecting sites of infection and inflammation in a mammal comprising administering to the mammal a radio-labeled LTB4 binding agent (as described above) and then detecting the sites using a radiation detecting probe or planar or ring gamma camera. Also disclosed are the compounds of formula:  We' - O - (CR54R55)k" - Y' wherein: We' is a substituted pyridyl derivative as defined in the specification, or an optional substituted hydroxyphenyl derivative as defined in the specification; R54 and R55 are independently selected from the group: H, Alkyl, alkoxy, or R54 and R55 may be taken together to from a 3-6 membered cycloalkyl; k" is 4-7 Y' is selected from the group: C(=O)NHR56, NHC(=O)R56 and NHC(=O)NHR57 The compounds of formula We' - O - (CR54R55)k" - Y' are useful in the manufacture of a medicament for treating disease in a mammal associated with infection and disease.
Patent NZ-516092-A (NZ)
Title: Dosing device adapted for dispensing a concentrate from a holder in a metered manner
Inventor: BRAMER ALBERTUS MARIA
IPC: B65B37/06
Filed: 2000-06-20
Abstract: A dosing device (1) comprising a housing (6a, 6b) with at least one inlet (2), at least one outlet (4), and a liquid flow path extending from the inlet (2) to the outlet (4). The dosing device (1) is adapted for dispensing in a metered manner a viscous concentrate from a holder. The concentrate in diluted condition forms a beverage suitable for consumption. The dosing device (1) is adapted to be connected, in use, to a storage space of the holder. Also the dosing device (1) comprises a gear pump (8) to be included in the liquid flow path, which gear pump (8) can be driven in particular by a rotor (22) located upstream of the gear pump (8), by means of changing magnetic fields.
Patent NZ-516335-A (NZ)
Title: C-pyrazole substituted 6-amino-purine derivatives useful as A2A receptor agonists
Inventor: ZABLOCKI JEFF A
IPC: A61P9/00
Filed: 2000-06-21
Abstract: A purine derivative has the formula (I) wherein: R1 is -CH2OH or -C(=O)NR5R6 ; R2 is hydrogen or optionally substituted alkyl, alkenyl, alkynyl, heterocyclyl, aryl or heteroaryl; R3 and R4 are independently hydrogen or optionally substituted alkyl, alkenyl, alkynyl, heterocyclyl, aryl or heteroaryl or halo, NO2, CF3, CN, OR20, SR20, N(R20)2, S(O)R22, SO2R22, SO2N(R20)2, SO2NR20COR22, SO2NR20CO2R22, SO2NR20CON(R20)2, N( R20)2, NR20COR22, NR20CO2R22, NR20CON(R20)2, COR20, CO2R20, CON(R20)2, CONR20SO2R22, NR20SO2 R22, SO2NR20CO2R22, OCONR20SO2R22, OC(O)R20, C(O)OCH2OC(O)R20 or OCON(R20)2; R5 and R6 are independently H or substituted alkyl ; R20 is H or optionally substituted alkyl, alkenyl, alkynyl, heterocyclyl, aryl, or heteroaryl; and R22 is optionally substituted alkyl, alkenyl, alkynyl, heterocyclyl, aryl or heteroaryl; provided when R1 is CH2OH, R3 is H, R4 is H, and the pyrazole ring is attached through C4, and R2 is not H. The compounds are useful for stimulating coronary vasodilatation so to stress the heart and induce a coronary steal situation for the purposes of imaging the heart.
Patent NZ-518625-A (NZ)
Title: Fish grading device
Inventor: JOHNSON IVOR GILBERT
IPC: A01K61/90
Filed: 2000-11-03
Abstract: A fish grading device (1) is formed from an array of generally rectangular apertures (2), each of which is formed by two long tubes (3) and two short tubes (4) of plastics material mounted to a loop of fishing net (5).  Each loop of fishing net (5) is formed by crimping the ends of the loop by means of a metal crimp (6).  Each of the tubes (3, 4) can rotate freely about its longitudinal axis, so that a fish brushing against a tube (3, 4) will cause the tube to rotate, and will therefore avoid becoming snagged on the tube.  When such a fish grading device (1) is included in a fishing net and the net is dragged through the water, small fish are able to swim through the rectangular apertures (2), whereas larger fish are not.  Thus only fish of a desired minimum size are caught.
Patent NZ-519983-A (NZ)
Title: Electro therapy method and apparatus
Inventor: CARTER JOHN
IPC: A61N1/34
Filed: 2001-01-08
Abstract: An electro-therapy apparatus providing therapeutic electric current to a treatment site of a patient comprises:- (a) A signal generator forming a first and second signals having a frequency difference of between 1 Hz and 250 Hz, each signal having a frequency at least about 1 KHz; (b) A single feed electrode connected to the signal generator and adapted to output a therapeutic signal to at least one feed site on or beneath a first epidermal or mucous membrane surface of the patient; (c) At least one return electrode adapted to be positioned on or beneath a second epidermal or mucous membrane surface of the patient, locally to the treatment site; (d) The first and second signals being sinusoidal alternating current signals; and (f) The therapeutic signal formed from the first and second signals prior to being output to at least one feed site. The apparatus is useful in relieving pain arising from temporary or chronic conditions during or after surgery.
Patent NZ-520563-A (NZ)
Title: Intersystem (GSM, CDMA) base station handover by simultaneously communicating with both base stations
Inventor: GRILLI FRANCESCO
IPC: H04B17/40
Filed: 2001-03-07
Abstract: Methods and apparatus for handing over a mobile station in the system from a CDMA base station to a GSM/TDMA base station are disclosed. A hybrid GSM/CDMA telecommunications system 20 includes base stations 32 operating according to a CDMA interface, and base stations 30 operating according to a GSM/TDMA interface. A communications link is established over the CDMA interface with a mobile station 40. Data is received at the CDMA station from the mobile station 40, in response to a signal received by the mobile station over the GSM/TDMA interface, without breaking the communications link with the CDMA station. The data includes a measurement of the signal strength. The mobile station is handed over from the CDMA to the GSM/TDMA base station in response to the data received, while a weighting factor is applied to the measurement of the signal strength. In particular, a method of conducting intersystem handover from a multicarrier system to a direct spread system is provided. Timing synchronization is also made available through the mobile station.
Patent NZ-521791-A (NZ)
Title: Polymer modified inorganic coatings
Inventor: BARBER ROBERT FREDERICK
IPC: C09D1/08
Filed: 2001-04-04
Abstract: An anhydrous cementitous coating composition comprising: a) hydraulic cement in the range of 30 to 70% w/w; b) polymeric particles having a Tg less than 25oC in the range 5 to 24% w/w; c) mineral extender particles in the range 5 to 50% w/w. The cement to mineral extender particles are in the weight ratio 5:1 to 1:1.
Patent NZ-522973-A (NZ)
Title: An injector device for delivery of liquid from a high pressure
Inventor: HJERTMAN BIRGER
IPC: A61M5/24
Filed: 2001-05-22
Abstract: An injector device for delivery of liquid from a high pressure, the device comprising a housing, a pressure chamber (2) comprising a pressure barrel (4) for accommodation of at least one piston therein and having a front end opening (6) for ejection of the liquid, the pressure chamber being of sufficient strength to sustain the liquid pressure. The device further comprises a storage chamber (16), separate from the pressure chamber, for the liquid or the liquid precursor components, and a conduit (22) between the pressure chamber and the storage chamber. A pressurizing mechanism (26) in the housing is arranged to apply force, directly or indirectly, on the piston in the pressure barrel to create the liquid pressure. The pressure chamber, the piston and at least a part of the conduit is arranged as a unit, wherein the unit and the housing have corresponding fitting parts allowing releasable attachment of the unit to the housing in a position permitting fluid connection between storage chamber and pressure chamber through the conduit and permitting the pressurizing mechanism to act on the piston.
Patent NZ-528618-A (NZ)
Title: Tamper evident container
Inventor: DAFFURN PAUL
IPC: B65D85/72
Filed: 2003-10-03
Abstract: A tamper evident container including a base member and a co- operating lid or closure therefore, said lid being resiliently snap-fitting on said base member by having one or more formations thereon adapted to engage one or more co- operating formations of said base member, and additionally at least one section of said lid and said base member being initially secured to an abutting part of the other one of said lid and said base member, whereby when said lid is first removed from the base member the or each said section of said one of said lid and said base member is detached from said one and remains secured to the other of said lid and said base member, thereby to provide evidence to a user of opening of said container.
Patent NZ-529933-A (NZ)
Title: Polymorphic crystalline forms of celecoxib
Inventor: FERRO LEONARD J
IPC: A61K9/26
Filed: 2000-12-01
Abstract: Describes a solid form of celecoxib comprising Form I celecoxib and Form III celecoxib, and methods of preparation of a Form I crystalline form of celecoxib having: an X-ray powder diffraction pattern with a peak at about 5.5, 5.7 7.2 or 16.6 degrees two theta; a melting range from about 160degree C to about 164degree C; the crystalline form of any one of claims 1 to 5 having an Infrared Spectrum which has a peak at about 3250 to about 3260 cm-1, 3350 to about 3360 cm-1. Further describes the use of Form I celecoxib in the preparation of a medicament for treating or preventing a cyclooxygenase-2-mediated condition or disorder in a subject. (62) Divided out of 514059
Patent NZ-530801-A (NZ)
Title: A fencing
Inventor: BAUER BURKHARD
IPC: A01M29/34
Filed: 2002-07-05
Abstract: Fencing for preventing insects to enter an open air area comprising a substantially upright structure with a height suitable to prevent low flying insects to enter the open air area is disclosed. The structure of the fencing is impregnated with an insecticide.
Patent NZ-533525-A (NZ)
Title: Probe for testing stability of snow or soil
Inventor: MACKENZIE RODERICK
IPC: G01L5/00
Filed: 2002-12-23
Abstract: A penetrating probe for testing soil or snow stability is disclosed. The probe has a shaped head 20 that contains a sensing unit for sensing the resistance to penetration of the head into snow or soil. The sensing unit includes a load cell 24 incorporating a low duro polymer where the impact of the head when impacting snow or soil is transferred to the low duro polymer. An accelerometer is also included to sense the acceleration of the head as it moves. A processor analyses data received from the sensors and presents it as a vertical profile of penetration resistance with depth of penetration.
Patent NZ-541794-A (NZ)
Title: 3-Substituted-2(arylalkyl)-1-azabicycloalkanes and methods of use thereof
Inventor: MAZUROV ANATOLY A
IPC: A61K51/00
Filed: 2004-02-20
Abstract: Disclosed are compounds of formulae 1 and 2, wherein: m and n individually are 1 or 2, p is 1, 2, 3 or 4, X is oxygen or NR', Y is oxygen or sulfur, Z is NR', a covalent bond or a linker species A, wherein A is selected from the group -CR'R"-, -CR'R"-CR'R"-, -CR'=CR'-, and -C2-, wherein when Z is a covalent bond or A, X must be nitrogen, and the remaining substituents are as defined in the specification. The compounds are capable of affecting nicotinic acetylcholinergic receptors and are useful in the treatment of central and autonomic nervous system disorders.
Patent NZ-544761-A (NZ)
Title: 7-Carboxymethyloxy-3', 4', 5-trimethoxy flavone monohydrate, the preparation method and uses thereof
Inventor: YOO MOOHI
IPC: A61P1/00
Filed: 2004-09-04
Abstract: Disclosed are monohydrates and solvates of 7-carboxymethyloxy-3',4',5-trimethoxy flavone, also known as DA-6034, and processes for their preparation. The compounds are useful for the protection of the gastrointestinal tract including the colon and the treatment of gastrointestinal diseases selected from gastritis, gastric ulcer, ulcerative colitis and Crohn's disease.
Patent NZ-545862-A (NZ)
Title: 2-Methylene-19-nor-vitamin D2 compounds
Inventor: DELUCA HECTOR F
IPC: A61K31/59
Filed: 2004-08-18
Abstract: Disclosed is a compound of formula (IA) or (IB), a pharmaceutically acceptable salt of the compound, or a mixture thereof. Also disclosed is the use of the above compound in the manufacture of a medicament for the treatment of bone diseases, psoriasis, leukaemia, colon cancer, breast cancer or prostate cancer or automimmune diseases or disorders.
Patent NZ-548823-A (NZ)
Title: Galenic formulations of organic compounds (oral dosage of aliskiren)
Inventor: RIGASSI-DIETRICH PETRA GISELA
IPC: A61K9/20
Filed: 2005-03-16
Abstract: Disclosed is a solid oral dosage form comprising; i) a therapeutically effective amount of aliskiren, or a pharmaceutically acceptable salt thereof, as active ingredient in an amount of more than 46 percent by weight based on the total weight of the oral dosage form, wherein the oral dosage form is in the form of a tablet or film-coated tablet and is not obtained by wet granulation with excipients using water and/or an aqueous binder solution. Also disclosed is the use of said oral dosage form in the treatment of hypertension angina and stroke and a process to prepare said dosage form.
Patent NZ-550862-A (NZ)
Title: Removable bracket for attachment to a ladder that rests on the roof of a building
Inventor: POLDMAA ARVO
IPC: E06C1/34
Filed: 2005-03-24
Abstract: A safety bracket 11 is removably attached to the top section of a ladder 12 and adapts the ladder 12 for use against the side of a building. The bracket 11 which extends away from the ladder 12 and will rest on the roof 14 of a building 15, has a pair of arms 18 joined by a cross member 19. The arms 18 are not parallel but diverge away from each other. The bracket 11 is joined to the ladder by a pair of adjustable braces 23 with one brace 23 on either side of the ladder 12. The braces 23 are used to adjust the angle between the plane of the ladder 12 and the bracket 11. Once the angle has been adjusted the bracket is locked into position.
Patent NZ-553071-A (NZ)
Title: Process for preparing bicyclic pyrazolyl compounds that act as cannabinoid receptor ligands
Inventor: BRANDT THOMAS ANDREW
Filed: 2005-09-15
Abstract: A process for preparing bicyclic pyrazolyl compounds of formula (I) is described herein, wherein the variables are as defined in the specification. These compounds have been shown to act as cannabinoid receptor ligands and are therefore useful in the treatment of disease linked to the mediation of the cannabinoid receptors in animals.
Patent NZ-555550-A (NZ)
Title: Method and apparatus for assisting the user of a sports ball to use or avoid spin by using a disc shaped ball
Inventor: HOFFMANN TIMOTHY
IPC: A63B43/00
Filed: 2005-12-13
Abstract: A sports training ball that that is substantially spherical is disclosed. The sports training ball has a disc shape formed by substantially parallel side surfaces separated by a circumferential surface which is shaped like part of a sphere. The sports training ball is used by a person training with the ball to assist in learning to impart spin and drift. The shape of the sports training ball will assist an observer to detect whether the throw, hit or bowl is properly achieved.
Patent NZ-562239-A (NZ)
Title: Three heaters coupled in a three-phase WYE configuration within a support conduit of an opening
Inventor: SANDBERG CHESTER LEDLIE
IPC: E21B36/00
Filed: 2006-04-21
Abstract: Disclosed is a heating system for a subsurface formation. The heating system includes a first heater (212), a second heater (212), and a third heater (212) placed in a support conduit in a single opening in the subsurface formation. Each heater includes an electrical conductor (218), an insulation layer (220) at least partially surrounding the electrical conductor, and an electrically conductive sheath (222) at least partially surrounding the insulation layer. The electrical conductor is electrically coupled to the sheath at a lower end portion of the heater. The lower end portion is the portion of the heater distal from a surface of the opening. The first heater, the second heater, and the third heater are electrically coupled at the lower end portions of the heaters. The first heater, the second heater, and the third heater are electrically coupled in a three-phase wye configuration.
Patent NZ-562942-A (NZ)
Title: Polyethylene glycol colonic purgative composition
Inventor: ROSE MARTIN
IPC: A61K9/14
Filed: 2006-05-08
Abstract: Disclosed herein is a solid dosage colonic purgative formulation for oral administration comprising a therapeutically effective amount of polyethylene glycol having an average molecular weight of 8000, electrolytes and a lubricant, wherein the formulation comprises between about 50w/w% to about 90 w/w% PEG 8000. Said dosage is useful for purging the colon of a patient.
Patent NZ-563548-A (NZ)
Title: A portable crozer for barrels
Inventor: WATERMAN BRECK
Filed: 2007-11-21
Abstract: A crozer for barrels is disclosed. The crozer 10 includes a mounting means for securing the crozer to an end of the barrel 12. At least a first cutting means 32 is rotatably associated with the mounting means. The cutting means is configured to form a groove, or croze 38 along an inside surface 36 of the barrel adjacent to the end, the groove is adapted to accommodate a barrel head.
Patent NZ-574801-A (NZ)
Title: A releasably mountable actuator for use in controlling the opening or closing of a barrier or gateway
Inventor: LYNCH GRAHAM BRUCE
IPC: E05B47/00
Filed: 2010-05-11
Abstract: An actuator apparatus for use in controlling the opening or closing of a barrier or gateway, and a remote control system for operating the actuator apparatus is disclosed. The actuator apparatus includes a controller, a power supply, and an actuator all configured in and about a housing and capable of being releasably mountable to the barrier or gateway. The controller includes a receiver for receiving, in use, a remote control trigger signal and generates an output control signal to initiate the actuator where the actuator drives and actuates a latch member when triggered by the control means.
Patent NZ-586993-A (NZ)
Title: New dihydroindolone compounds, a process for their preparation and phamaceutical compositions containing them
Inventor: ORTUNO JEAN-CLAUDE
IPC: C07D403/04
Filed: 2010-07-23
Abstract: Dihydroindolone derivatives of formula (I) and their optical and geometric isomers, and addition salts with an acid or base are disclosed, wherein the variables are as defined in the specification. The disclosure also relates to (1) the preparations of these dihydroindolone derivatives; (2) the use of these dihydroindolone derivatives for the treatment of cancers, particularly cancers of the colon, breast, liver, kidneys, brain, oesophagus, melanomas, myelomas, cancers of the ovary, non-small cell lung cancers, small cell lung cancers, cancers of the prostate and pancreas, and sarcomas; and (3) combination comprising these dihydroindolone derivatives with an anticancer agent comprising genotoxic agents, mitotic poisons, antimetabolites, proteasome inhibitors or kinase inhibitors.
Patent NZ-592626-A (NZ)
Title: Processes for the preparation of bendamustine
Inventor: CHEN JIAN
IPC: C07D235/16
Filed: 2009-10-07
Abstract: 592626 Disclosed is a process for the preparation of a Bendamustine precursor 4-{ S-Bis-(2-chloro-ethyl)-amino[-1-methyl-1H-benzoimidazo1-2-yl]-butyric acid ester of formula I or a pharmaceutically acceptable salt thereof, wherein R is a masked carboxylic acid, the process comprising the step of: reductively alkylating with chloroacetic acid or chloro acetaldehyde, a 4-(S-Amino-1-methyl-1H-benzoimidazol-2-yl)-butyric acid ester of formula II or a pharmaceutically acceptable saIt thereof.
Patent NZ-596876-A (NZ)
Title: Dermal delivery compositions comprising active agent-calcium phosphate particle complexes and methods of using the same
Inventor: MANSOURI ZAHRA
IPC: A61K9/16
Filed: 2010-05-06
Abstract: 596876 Disclosed herein are dermal delivery compositions. Aspects of the dermal delivery compositions include the presence of active agent-calcium phosphate particle complexes, where these complexes include uniform, rigid, spherical nanoporous calcium phosphate particles wherein at least 90% of the particles have a particle diameter of 2 microns or less wherein the particles are complexed with one or more active agents. Also disclosed are methods of using the compositions in active agent delivery applications.
Patent NZ-597070-A (NZ)
Title: Radionuclide generator designed to prevent excess liquid from being introduced during sterilisation
Inventor: EVERS JOHN HENRY
IPC: G21H5/00
Filed: 2009-05-13
Abstract: 597070 Disclosed is a method of producing a terminally sterile column (12) of a radionuclide generator. The method includes providing a column assembly (10) of a radionuclide generator. The assembly (10) has a column (12) having a long-lived parent radionuclide that produces a relatively short-lived daughter radionuclide; an inlet port (14) in fluid communication with the column (12); and an outlet port (30) in fluid communication with the column (12). The outlet port (30) includes a vent opening (26) that provides fluid access to the column (12). The column assembly (10) is positioned in an orientation with the vent opening (26) facing downwardly to prevent condensate from entering the vent opening (26) from above. The column assembly (10) is exposed to steam for sterilization.